Pekin Hardy Strauss’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.73M Buy
201,082
+120,832
+151% +$1.95M 0.24% 108
2026
Q2
$1.65M Sell
80,250
-168,130
-68% -$3.85M 0.15% 159
2026
Q1
$5.47M Sell
248,380
-773
-0.3% -$13.5K 0.57% 48
2025
Q4
$2.94M Sell
249,153
-92,400
-27% -$1.19M 0.27% 94
2025
Q3
$5.41M Sell
341,553
-38,845
-10% -$563K 0.54% 49
2025
Q2
$4.36M Buy
380,398
+79,791
+27% +$899K 0.5% 54
2025
Q1
$4.07M Buy
+300,607
New +$4.99M 0.49% 56

Other funds holding CC

Pekin Hardy Strauss's CC Position: Q3 2026 in Review

Pekin Hardy Strauss increased its Chemours (CC) stake by 151% in Q3 2026, buying an estimated $1.95M and bringing the position to 201,082 shares worth $2.73M. The position accounts for 0.24% of the portfolio, ranked #108.

Pekin Hardy Strauss first reported a position in CC in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.47M in Q1 2026. 360 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Pekin Hardy Strauss held 201,082 shares of Chemours worth $2.73M as of Q3 2026.
  • Pekin Hardy Strauss bought 120,832 Chemours shares in Q3 2026, an estimated $1.95M.
  • Chemours made up 0.24% of Pekin Hardy Strauss's portfolio in Q3 2026, its #108 holding.
  • Pekin Hardy Strauss first reported a position in Chemours in Q1 2025 and has held it in 7 quarters since.
  • Pekin Hardy Strauss's Chemours position peaked at $5.47M in Q1 2026.
  • 360 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Pekin Hardy Strauss's 13F filing for Q3 2026, filed 2 Nov 2026.